Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis
Alexandra B. Hogan, Peter Winskill, Oliver J. Watson, Patrick G. T. Walker, Charles Whittaker, Marc Baguelin, Nicholas F. Brazeau, Giovanni D. Charles, Katy A. M. Gaythorpe, Arran Hamlet, Edward Knock, Daniel J. Laydon, John A. Lees, Alessandra Løchen, Robert Verity, Lilith K. Whittles, Farzana Muhib, Katharina Hauck, Neil M. Ferguson, Azra C. Ghani
May 2021Aged
COVID-19
COVID-19 Vaccines
Humans
Mathematical model
Models
Theoretical
Optimisation
Public Health
SARS-CoV-2
Vaccination
Vaccination model
Vaccines
Related
- Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout
- The Burden of Malaria in the Democratic Republic of the Congo
- Modelling intensive care unit capacity under different epidemiological scenarios of the COVID-19 pandemic in three Western European countries
- Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India
- The epidemiology of Plasmodium vivax among adults in the Democratic Republic of the Congo